Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.221.261.211.17

What is the latest Fixed Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Fixed Capital/Sales ratio of PIRAMAL PHARMA is 1.22 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20241.22
Mar20231.26
Mar20221.21
Mar20211.17

How is Fixed Capital/Sales of PIRAMAL PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 1.22
-3.17
Mar2023 1.26
4.13
Mar2022 1.21
3.42
Mar2021 1.17 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Fixed Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,586.9 Cr 2.9% -12.7% 57.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,569.0 Cr 2.8% -7.5% 2.3% Stock Analytics
DIVIS LABORATORIES ₹146,318.0 Cr -0.2% -9.9% 60.4% Stock Analytics
CIPLA ₹118,110.0 Cr 4.4% -0.6% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,926.0 Cr 4.8% -2.9% 15.4% Stock Analytics
DR REDDYS LABORATORIES ₹93,471.5 Cr NA -9.4% -10.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.9%

-12.7%

57.8%

SENSEX

1.4%

-5.3%

0.3%


You may also like the below Video Courses